Supplementary methods

Differentiation of hiPSC into cardiomyocytes
Differentiation of hiPSC to cardiomyocytes (CM) was performed by following a previously reported protocol based on small molecules-mediated canonical Wnt pathway modulation 1 .
Briefly, differentiation was initiated by a 24h treatment with CHIR99021 (12uM, Selleckchem)
followed by Wnt pathway inhibition mediated by IWP-4 (5uM, Stemgent) on days 4 and 5. The differentiating cells were cultured in RPMI medium supplemented with B27 without insulin for 7days and in presence of insulin from day 8 to day 30. Enrichment for CM was achieved by switching the culture medium to DMEM supplemented with lactic acid (4mM) in substitution of glucose for 6 day as previously reported 2 .
Dissociation of hiPSC-CMs into single cells
hiPSC-CM-enriched cultures were dissociated following an protocol optimized from one previously described for isolation of rabbit sinoatrial node cells 3 
Figure S7
Dot plots of plateau amplitudes, measured 20 ms after initiation of the action potential upstroke.
The dotted line indicates the cutoff value of 85 mV, distinguishing 'atrial'-like action potentials from 'ventricular'-like. This parameter was found to be highly discriminating in a previously published report, in which atrial-specific human embryonic stem cells derived-cardiomyocytes (hESC-CMs) were generated and characterized in detail 4 . Based on this parameter, the vast majority of cells generated with our differentiation protocol displayed a 'ventricular'-like action potential. The proportion of cells exhibiting 'ventricular'-like action potentials was not different across the groups (p=0.3, Fisher's exact test).
